Breaking News, Promotions & Moves

AMRI CEO To Retire

Marth to succeed D'Ambra

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Thomas E. D’Ambra, Ph.D. will retire as president and chief executive officer of Albany Molecular Research, Inc. (AMRI), effective December 31, 2013. Dr. D’Ambra will serve as the company’s non-executive chairman of the board at that time. William S. Marth, currently non-executive chairman of the AMRI board, will take over Dr. D’Ambra’s role, effective January 1, 2014. Mr. Marth will remain a member of the company’s board.   Mr. Marth brings global experience in str...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters